Drreddys Laboratories | RDY - Nettoeinkommen





Nettoeinkommen Veränderung Datum
ANI Pharmaceuticals USD 35.15M 10.44M 2026-09
Aurora Cannabis CAD -4.03M 67.07M 2026-06
Bayer EUR -672M 891M 2026-09
Canopy Growth CAD -14.58M 142.54M 2026-06
Cipla INR 8.78B 884.9M 2026-09
Corcept Therapeutics USD 124.49M 82.35M 2026-09
Drreddys Laboratories INR 9.25B 7.04B 2026-09
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
Hikma Pharmaceutical USD 164M 45M 2025-12
Lonza CHF 426M 119M 2025-06
Novartis USD 1.2B 2.06B 2026-09
Pacira USD 325.3M 320.65M 2026-09
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 38.54M 15.39M 2026-06
Richter Gedeon HUF 38.26B 27.02B 2026-06
Sun Pharmaceuticals INR 19.89B 9.06B 2026-09
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
Teva Pharmaceutical Industries USD 233M 809M 2026-09